These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2029187)

  • 1. [The value of a Tenckhoff catheter in ovarian cancer].
    Kato N; Arakawa A; Yasui Y; Suzumori K; Suzumori K; Yagami Y
    Gan To Kagaku Ryoho; 1991 May; 18(6):1025-30. PubMed ID: 2029187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Intraperitoneal chemotherapy of CDDP and etoposide in patients with advanced ovarian cancer].
    Hirashima Y; Shimura T; Tanaka Y; Demukai H; Kubota T; Kobayashi T; Suzuki A
    Gan To Kagaku Ryoho; 1993 Aug; 20(10):1321-6. PubMed ID: 8346930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Intraperitoneal high-dose cisplatinum chemotherapy (CDDP-ip) in patients with carcinomatous peritonitis].
    Noda T; Oku M; Kiyozuka Y; Ninomiya Y; Hino K; Okamura Y; Maruyama M; Ichijo M
    Gan To Kagaku Ryoho; 1987 Apr; 14(4):1025-32. PubMed ID: 3566301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Intraperitoneal (Ip) administration of cisplatin in combination with systemic chemotherapy in patients with malignant ascites of gastrointestinal cancer: clinical evaluation and pharmacokinetics].
    Koda K; Nakazawa O; Terada S; Kure T; Morita K; Hirayama M; Fukushi A; Terui T; Yoshizaki N; Takahashi H
    Gan No Rinsho; 1988 Feb; 34(2):191-5. PubMed ID: 3126333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Intraperitoneal (i.p.) chemotherapy in the management of ovarian cancer--pharmacokinetics and methods of sequential i.p. chemotherapy].
    Noda T; Adachi S; Yamamoto T; Hirooka C; Kiyozuka Y; Adachi S; Oku M; Ichijo M
    Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 2):1561-8. PubMed ID: 2389949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chemotherapy in malignant gynecologic tumors using intraperitoneal catheter with a subcutaneous reservoir].
    Shimizu A; Kimura T; Funatsu M; Hada Y; Araki H; Notake Y
    Gan To Kagaku Ryoho; 1991 Aug; 18(11):1795-9. PubMed ID: 1877820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intraperitoneal chemotherapy using CBDCA for malignant gynecological tumors].
    Shimizu A; Kimura T; Funatsu M; Hada Y; Tamura K; Taguchi A; Miyakawa Z; Notake Y
    Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1738-41. PubMed ID: 1530345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II trial of combination intraperitoneal cisplatin and 5-fluorouracil in previously treated patients with advanced ovarian cancer: long-term follow-up.
    Morgan RJ; Braly P; Leong L; Shibata S; Margolin K; Somlo G; McNamara M; Longmate J; Schinke S; Raschko J; Nagasawa S; Kogut N; Najera L; Johnson D; Doroshow JH
    Gynecol Oncol; 2000 Jun; 77(3):433-8. PubMed ID: 10831355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacokinetic study of intraperitoneal cisplatin chemotherapy for gastric cancer as an adjuvant setting].
    Kochi M; Fujii M; Takano S; Kato Y; Kawakami T; Kanamori N; Iwai S; Tanaka T
    Gan To Kagaku Ryoho; 1995 Sep; 22(11):1535-7. PubMed ID: 7574752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapy of infections related to intraperitoneal catheters in patients with ovarian cancer.
    Meunier F; van der Auwera P; Aoun M; Piccart M; Sculier JP
    Scand J Infect Dis Suppl; 1990; 72():26-8. PubMed ID: 2151063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase II trial of intraperitoneal cisplatin and etoposide as consolidation therapy in patients with Stage II-IV epithelial ovarian cancer following negative surgical assessment.
    Barakat RR; Almadrones L; Venkatraman ES; Aghajanian C; Brown C; Shapiro F; Curtin JP; Spriggs D
    Gynecol Oncol; 1998 Apr; 69(1):17-22. PubMed ID: 9570993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Intraperitoneal chemotherapy of metastatic ovarian cancer].
    Hasegawa E; Watanabe H; Ohmura G; Hirakawa S; Momose K
    Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1742-4. PubMed ID: 1530346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacokinetics following intraperitoneal infusion of cisplatinum with and without sodium thiosulfate rescue in carcinomatous peritonitis in advanced gastric cancers].
    Namatame K; Kou Y; Nakayoshi A
    Gan To Kagaku Ryoho; 1991 Aug; 18(11):1784-9. PubMed ID: 1877818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Problems associated with the administration of intraperitoneal therapy using the Port-A-Cath system.
    Almadrones L; Yerys C
    Oncol Nurs Forum; 1990; 17(1):75-80. PubMed ID: 2300507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental and clinical evaluation of cisplatin-containing microspheres as intraperitoneal chemotherapy for ovarian cancer.
    Sugiyama T; Kumagai S; Nishida T; Ushijima K; Matsuo T; Yakushiji M; Hyon SH; Ikada Y
    Anticancer Res; 1998; 18(4B):2837-42. PubMed ID: 9713471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experience with implanted subcutaneous ports for intraperitoneal chemotherapy in ovarian cancer.
    Malmström H; Carstensen J; Simonsen E
    Gynecol Oncol; 1994 Jul; 54(1):27-34. PubMed ID: 8020835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacokinetics and toxicological study on the intraperitoneal administration of cisplatin and etoposide in gynecological malignancies].
    Fujimoto R; Yanagawa Y; Yamada T; Ueki K; Takahara T; Kumagai K; Okamura S; Ueki M; Sugimoto O
    Gan To Kagaku Ryoho; 1992 Sep; 19(11):1843-9. PubMed ID: 1519927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complications relating to intraperitoneal administration of cisplatin or carboplatin for ovarian carcinoma.
    Sakuragi N; Nakajima A; Nomura E; Noro N; Yamada H; Yamamoto R; Fujimoto S
    Gynecol Oncol; 2000 Dec; 79(3):420-3. PubMed ID: 11104613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraperitoneal high-dose cisplatin and etoposide with systemic thiosulfate protection in second-line treatment of advanced ovarian cancer.
    Malmström H; Rasmussen S; Simonsen E
    Gynecol Oncol; 1993 May; 49(2):166-71. PubMed ID: 8504983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II trial of intraperitoneal cisplatin with intravenous doxorubicin and cyclophosphamide in previously untreated patients with advanced ovarian cancer-long-term follow-up.
    Morgan RJ; Braly P; Cecchi G; Leong L; Shibata S; Margolin K; Somlo G; McNamara M; Longmate J; Schinke S; Raschko J; Nagasawa S; Kogut N; Parker P; Stein A; Cho J; Smith E; Coluzzi P; Najera L; Johnson D; Womack E; Doroshow JH
    Gynecol Oncol; 1999 Dec; 75(3):419-26. PubMed ID: 10600300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.